Recruiting
Phase 2

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Sponsor:

University of Arizona

Code:

NCT04838301

Conditions

Alzheimer Dementia

Late Onset Alzheimer Disease

Neurodegenerative Diseases

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

Allopregnanolone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information